FDA Warning Letter — Seafane

Case 735052 — FEI 3040802611

The FDA took a Warning Letter action against Seafane on Sep 25, 2026 (Roselle, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Seafane
Date
Sep 25, 2026
Fiscal Year
2026
Product Type
Tobacco
Center
CTP
Location
Roselle, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.